ZA992971B - Aryl fused azapolycyclic compounds. - Google Patents

Aryl fused azapolycyclic compounds.

Info

Publication number
ZA992971B
ZA992971B ZA9902971A ZA992971A ZA992971B ZA 992971 B ZA992971 B ZA 992971B ZA 9902971 A ZA9902971 A ZA 9902971A ZA 992971 A ZA992971 A ZA 992971A ZA 992971 B ZA992971 B ZA 992971B
Authority
ZA
South Africa
Prior art keywords
aryl fused
fused azapolycyclic
azapolycyclic compounds
compounds
aryl
Prior art date
Application number
ZA9902971A
Other languages
English (en)
Inventor
Jotham Wadsworth Coe
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA992971B publication Critical patent/ZA992971B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
ZA9902971A 1998-04-29 1999-04-28 Aryl fused azapolycyclic compounds. ZA992971B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8355698P 1998-04-29 1998-04-29

Publications (1)

Publication Number Publication Date
ZA992971B true ZA992971B (en) 2000-10-30

Family

ID=22179102

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9902971A ZA992971B (en) 1998-04-29 1999-04-28 Aryl fused azapolycyclic compounds.

Country Status (42)

Country Link
US (3) US6462035B1 (no)
EP (1) EP1076650B1 (no)
JP (1) JP2002513007A (no)
KR (1) KR100420423B1 (no)
CN (1) CN1144787C (no)
AP (1) AP1154A (no)
AR (1) AR018596A1 (no)
AT (1) ATE258921T1 (no)
AU (1) AU749831B2 (no)
BG (1) BG64556B1 (no)
BR (1) BR9910058A (no)
CA (1) CA2330576A1 (no)
CO (1) CO5021124A1 (no)
DE (1) DE69914594T2 (no)
DK (1) DK1076650T3 (no)
DZ (1) DZ2778A1 (no)
EA (1) EA003669B1 (no)
ES (1) ES2213354T3 (no)
GT (1) GT199900059A (no)
HK (1) HK1036453A1 (no)
HR (1) HRP20000731A2 (no)
HU (1) HUP0103340A3 (no)
ID (1) ID26700A (no)
IL (1) IL138917A0 (no)
IS (1) IS5649A (no)
MA (1) MA26623A1 (no)
MY (1) MY133474A (no)
NO (1) NO317300B1 (no)
NZ (1) NZ507035A (no)
OA (1) OA11506A (no)
PA (1) PA8471301A1 (no)
PE (1) PE20000435A1 (no)
PL (1) PL344010A1 (no)
PT (1) PT1076650E (no)
SK (1) SK15952000A3 (no)
TN (1) TNSN99080A1 (no)
TR (1) TR200003122T2 (no)
UA (1) UA61991C2 (no)
UY (1) UY25636A1 (no)
WO (1) WO1999055680A1 (no)
YU (1) YU64400A (no)
ZA (1) ZA992971B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1044189T4 (en) 1997-12-31 2015-03-30 Pfizer Prod Inc Aryl-fused fused azapolycyclic connections
US6605610B1 (en) * 1997-12-31 2003-08-12 Pfizer Inc Aryl fused azapolycyclic compounds
US20010036943A1 (en) * 2000-04-07 2001-11-01 Coe Jotham W. Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
MXPA03009527A (es) * 2001-04-20 2004-02-12 Pfizer Prod Inc PROCEDIMIENTO PARA LA PREPARACIoN DE INDENOS 1,3-SUSTITUIDOS Y COMPUESTOS AZAPOLICICLICOS CONDENSADOS CON ARILO.
JP2005507411A (ja) * 2001-10-31 2005-03-17 ファイザー・プロダクツ・インク 下肢静止不能症候群の治療における、ニコチン性アセチルコリン受容体アゴニスト。
EP1451202B1 (en) 2001-11-30 2008-08-20 Pfizer Products Inc. Aryl fused azapolycyclic compounds
WO2003093258A2 (en) * 2002-05-03 2003-11-13 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Novel spiro ketone and carboxylic acid derivatives as specific inhibitors for (po3h2) ser/(po3h2)thr-pro-specific peptidyl-prolyl-cis/trans-isomerases
US20040224963A1 (en) * 2003-05-09 2004-11-11 Pfizer Inc Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
US20040224962A1 (en) * 2003-05-09 2004-11-11 Pfizer Inc Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
WO2005007630A2 (en) * 2003-07-21 2005-01-27 Pfizer Products Inc. Aryl fused azapolycyclic compounds
CA2529193A1 (en) 2003-07-21 2005-01-27 Pfizer Products Inc. Nicotine addiction reducing heteroaryl fused azapolycyclic compounds
US20050043407A1 (en) * 2003-08-22 2005-02-24 Pfizer Inc Pharmaceutical composition for the prevention and treatment of addiction in a mammal
WO2006061711A1 (en) * 2004-12-07 2006-06-15 Pfizer Products Inc. 1, 2, 3, 3a, 8, 8a-hexahydro-2, 7a-diada-cyclopenta [a] inden-7-one derivatives which bind to neuronal nicotinic acetylcholine specific receptor sites and are useful in modulating cholinergic function and in the treatment of addictive disorders
US20060210497A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives
US20060210498A1 (en) 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
DE102005061426A1 (de) * 2005-12-22 2007-07-05 Grünenthal GmbH Substituierte tricyclische Piperidon-Derivate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687937A (en) * 1970-06-23 1972-08-29 Us Of America The 1,5-methano-3-benzazocine derivatives
JPS4914473A (no) * 1972-06-09 1974-02-07
JPS4924968A (no) * 1972-07-01 1974-03-05

Also Published As

Publication number Publication date
US20030008890A1 (en) 2003-01-09
US6462035B1 (en) 2002-10-08
HRP20000731A2 (en) 2001-06-30
NO20005397L (no) 2000-10-26
TR200003122T2 (tr) 2001-03-21
HUP0103340A2 (hu) 2002-02-28
SK15952000A3 (sk) 2002-06-04
KR20010043143A (ko) 2001-05-25
DZ2778A1 (fr) 2005-04-23
UA61991C2 (en) 2003-12-15
US6706702B2 (en) 2004-03-16
KR100420423B1 (ko) 2004-03-04
AP9901524A0 (en) 1999-06-30
CN1298394A (zh) 2001-06-06
US20040167149A1 (en) 2004-08-26
ES2213354T3 (es) 2004-08-16
HK1036453A1 (en) 2002-01-04
YU64400A (sh) 2003-01-31
BG104983A (en) 2001-09-28
AR018596A1 (es) 2001-11-28
NZ507035A (en) 2003-05-30
HUP0103340A3 (en) 2002-10-28
CN1144787C (zh) 2004-04-07
IS5649A (is) 2000-09-29
AP1154A (en) 2003-03-27
US7122534B2 (en) 2006-10-17
ATE258921T1 (de) 2004-02-15
ID26700A (id) 2001-02-01
UY25636A1 (es) 2000-02-23
NO317300B1 (no) 2004-10-04
PE20000435A1 (es) 2000-05-26
CO5021124A1 (es) 2001-03-27
CA2330576A1 (en) 1999-11-04
EA200000996A1 (ru) 2001-06-25
DK1076650T3 (da) 2004-05-24
TNSN99080A1 (fr) 2005-11-10
JP2002513007A (ja) 2002-05-08
IL138917A0 (en) 2001-11-25
EA003669B1 (ru) 2003-08-28
BG64556B1 (bg) 2005-07-29
PT1076650E (pt) 2004-05-31
EP1076650A1 (en) 2001-02-21
MA26623A1 (fr) 2004-12-20
AU2951699A (en) 1999-11-16
EP1076650B1 (en) 2004-02-04
DE69914594T2 (de) 2004-12-09
AU749831B2 (en) 2002-07-04
WO1999055680A1 (en) 1999-11-04
OA11506A (en) 2004-05-14
PA8471301A1 (es) 2000-09-29
PL344010A1 (en) 2001-09-24
BR9910058A (pt) 2000-12-26
NO20005397D0 (no) 2000-10-26
GT199900059A (es) 2000-10-11
DE69914594D1 (de) 2004-03-11
MY133474A (en) 2007-11-30

Similar Documents

Publication Publication Date Title
ZA9811911B (en) Aryl fused azapolycyclic compounds.
EG24814A (en) Novel compounds.
EG24743A (en) Heterocyclic compounds.
ZA200206768B (en) Aryl fused azapolycyclic compounds.
GB9804734D0 (en) Compounds
GB9804175D0 (en) Compounds
PL344796A1 (en) Aryl alkanoylpyridazines
ZA992971B (en) Aryl fused azapolycyclic compounds.
ZA992899B (en) Novel compound.
GB9809823D0 (en) Compounds
ZA986752B (en) Basimino-substituted phenyl compounds.
GB9810876D0 (en) Compounds
GB9801712D0 (en) Compounds
HK1028588A1 (en) Case.
GB9809217D0 (en) Compounds
HU0500571D0 (hu) Aril kondenzált azapoliciklusos vegyületek
SI1076650T1 (en) Aryl fused azapolycyclic compounds
ZA99985B (en) New compound.
ZA99942B (en) Novel compounds.
GB9805132D0 (en) Compounds
GB9806690D0 (en) Compounds
GB9803173D0 (en) Compounds
GB9805133D0 (en) Compounds
GB9805446D0 (en) Compounds
GB9805447D0 (en) Compounds